What one share of Aclarion holds
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), and proprietary biomarkers to optimize clinical treatments. Aclarion’s technology addresses the $134.5B U.S. low back and neck pain market, which according to a 2020 JAMA (Journal of the American Medical Association) article is now the most costly healthcare condition in the United States.
Aclarion’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.06 |
|---|---|
| Profit | −$6.25 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$5.51 |
| Cash and investments | $6.61 |
| Debt | $0.00 |
| Book value | $6.91 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $1.07 | −$105.22 | — | — | — | −$226.69 |
| 2022 | $0.16 | −$19.61 | — | — | — | $4.53 |
| 2025 | $0.14 | −$13.61 | $0.04 | −$13.51 | — | $15.02 |
Common questions about Aclarion
How much does one share of Aclarion earn?
Over the last 12 months, Aclarion lost $6.25 for each share on $0.06 of sales.
Does Aclarion pay a dividend?
Aclarion didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Aclarion’s book value per share?
Aclarion’s book value is $6.91 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Aclarion have?
Each share of Aclarion has $6.61 of cash and investments and $0.00 of debt, as of June 30, 2026.
What is Aclarion’s free cash flow per share?
−$5.51 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.